Search results
Results From The WOW.Com Content Network
An IB is intended to provide the investigator with insights necessary for management of study conduct and study subjects throughout a clinical trial. An IB may introduce key aspects and safety measures of a clinical trial protocol, such as: Dose (of the study drug) Frequency of dosing interval; Methods of administration; Safety monitoring ...
Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. [2] They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and ...
The Clinical Center provides an environment for both patient care and conducting clinical trials, most of which are in Phase I or Phase II. [1] In 2014, of the 773 active clinical trials protocols, 23% were Phase I trials (261 protocols), 60% were Phase II trials (462 protocols), 5% were Phase III (39 protocols) and 3% were Phase IV (11 ...
A study of trials conducted between 2008 and 2012 found that about half of those required to be reported had not been. [ 18 ] [ 19 ] A 2014 study of pre-2009 trials found that many had serious discrepancies between what was reported on clinicaltrials.gov versus the peer-reviewed journal articles reporting the same studies.
Lorne Elias is a Canadian chemist, inventor, and a pioneer in explosives detection technology. He invented the explosives vapour detector, EVD-1, a portable bomb detection instrument deployed at international airports in Canada in the 1980s.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
A protocol describes what types of people may participate in the trial; the schedule of tests, procedures, medications, and dosages; and the length of the study. While in a clinical trial, participants following a protocol are seen regularly by research staff to monitor their health and to determine the safety and effectiveness of their treatment.
Elias James Corey (born July 12, 1928) is an American organic chemist. In 1990, he won the Nobel Prize in Chemistry "for his development of the theory and methodology of organic synthesis ", [ 3 ] specifically retrosynthetic analysis .